X0202 SCHEDULE 13G 0002148795 XXXXXXXX LIVE Class A ordinary shares 07/27/2026 0001809616 Universe Pharmaceuticals INC G9442G138 265 Jingjiu Avenue Jinggangshan Economic and Technological Ji'an, Jiangxi F4 343100 Rule 13d-1(c) Orbis BioCapital Limited D8 0.00 499926.00 0.00 499926.00 499926.00 N 9.98 CO The amount in rows 6, 8 and 9 represents 499,926 Class A ordinary shares held by Orbis BioCapital Limited, a company with limited liability formed in the British Virgin Islands. Orbis BioCapital Limited is wholly owned and controlled by Chunhua Zheng, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026. Chunhua Zheng F4 0.00 499926.00 0.00 499926.00 499926.00 N 9.98 IN The amount in rows 6, 8 and 9 represents 499,926 Class A ordinary shares held by Orbis BioCapital Limited, a company with limited liability formed in the British Virgin Islands. Orbis BioCapital Limited is wholly owned and controlled by Chunhua Zheng, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026. Universe Pharmaceuticals INC 265 Jingjiu Avenue, Jinggangshan Economic and Technological, Ji'an, Jiangxi, CHINA, 343100 Orbis BioCapital Limited Chunhua Zheng Orbis BioCapital Limited: Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, British Virgin Islands Chunhua Zheng: Room 802, Unit 6, Huayuwan Zone A17, Kunming Sunac Cultural City, Xishan District, Kunming, Yunnan Province 650100, People's Republic of China Orbis BioCapital Limited: British Virgin Islands Chunhua Zheng: People's Republic of China Y Orbis BioCapital Limited: 499,926.00 Chunhua Zheng: 499,926.00 Orbis BioCapital Limited: 9.98% Chunhua Zheng: 9.98% See Row 5 of the cover page for each Reporting Person. See Row 6 of the cover page for each Reporting Person. See Row 7 of the cover page for each Reporting Person. See Row 8 of the cover page for each Reporting Person. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Exhibit 99.1 - Joint Filing Agreement Orbis BioCapital Limited /s/ Chunhua Zheng 09/01/2026 Chunhua Zheng /s/ Chunhua Zheng 09/01/2026